Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Main Content

MDS Officers and International Executive Committee

Open AllClose All
  Victor Fung - President-Elect 2021-2023, President 2023-2025

Personal Bio

Dr Fung is Conjoint Associate Professor at Sydney Medical School, The University of Sydney, and Director of the Movement Disorders Unit and Head, Department of Neurology, Westmead Hospital, Sydney, Australia. He is Co-Chair of the Publications and Communications Oversight Committee of the MDS. He has served as MDS Treasurer and on many committees, including as Chair of the Congress Scientific Program Committee, and contributes to a several Task Forces and Study Groups. He is Chair of the Asia Pacific Affairs Committee, Australian and New Zealand Association of Neurologists, and a past President of the Movement Disorder Society of Australia and New Zealand. He serves on Scientific Advisory Boards for various Australian patient organizations, has been on Scientific Program Committees and a speaker at various international conferences, and trained and mentored local and international Fellows. He is on the Editorial Boards of Movement Disorders, Movement Disorders Clinical Practice, npj Parkinson's Disease, Journal of Clinical Movement Disorders and F1000 Research. He has a clinical and research  interest in Parkinson’s disease and movement disorders, enjoying many international collaborations. 

Vision Statement

It has been a great privilege and pleasure to have already served the IPMDS in a number of different capacities. If elected President, I would continue to help guide the Society in pursuing its stated Purpose, Mission and Goals, in collaboration with the other Officers and membership. Specifically, I believe the mission of disseminating knowledge about movement disorders is well advanced and would prioritise facilitating equality of access to knowledge and integration of educational strategies across different Regions and educational platforms. With respect to promoting research into causes, prevention and treatment of Movement Disorders and care of patients, I would like to use the Society's influence as a peak body to enhance dissemination of knowledge, research and therapeutic advances in movement disorders, by greater engagement with governmental bodies, NGOs, the public and patient support groups. Equality of access to knowledge and therapies are the ultimate goals. In summary, I would enhance the advocacy and partnership activities of the MDS, while maintaining its already highly successful educational mission. 

The MDS has many extremely talented members, committed to its activities and translating thoughts and ideas into action. It listens to voices of all ages and experience, and in so doing is able to engage and harness the expertise of all of its membership. This egalitarian approach is almost unique for such a large organization, and helps to explain why it is able to attract such commitment. It would be an honour to have the opportunity to lead such a Society. 

  Marina de Koning-Tijssen - Secretary-Elect 2021-2023, Secretary 2023-2025

Personal Bio

Prof Marina AJ de Koning-Tijssen was trained as neurologist at Leiden University. She worked as a fellow with Prof DS Zee, Johns Hopkins University, Baltimore, USA and at the Institute of Neurology, Queen Square, London, UK (prof P Brown & Prof A Lees). Between 1999-2012 she worked as neurologist and PI in Amsterdam, finally taking on her current position as head of Movement Disorders at the University of Groningen. Over the years, she has supervised more than 30 PhD students and fellows, while regularly giving MDS lectures and organizing national and international congresses. Her research, Hyperkinetic Movement Disorders, encompasses neurological and psychiatric research, from basic patient care with a focus on phenotyping, to genetic and functional (neurophysiology and imaging) studies. She is chair of the Movement Disorder Expertise Centre Groningen, part of an European Reference Network, and official MDS training site. She is also currently a member of the MDS-IEC - and has contributed to the MDS as secretary of the MDS-ES, in several task forces, study groups, committees, and as a LEAP mentor. 

Vision Statement

I would like to see the MDS pursue an ambitious course focusing on both Parkinson disease and hyperkinetic movement disorders. With better education and increased collaboration worldwide, I aim to improve the quality of care for patients with both common and rare movement disorders. Increased collaboration will also lead to a higher quality of movement disorders research . One key to realizing this vision is inclusivity. Broader inclusion in the MDS is essential for a richer educational environment, and therefore I wish to promote more diversity, such as increased participation by younger and by female members. Through more education, collaboration, and inclusion I aim to positively contribute to the MDS, and improve care. 

  Wassilios Meissner - Treasurer-Elect 2021-2023, Treasurer 2023-2025

Personal Bio

Prof. Meissner is Head of the Department of Neurology for Neurodegenerative Diseases at the University Hospital Bordeaux and Deputy Director of the Institute for Neurodegenerative Diseases (CNRS UMR 5293) at the University Bordeaux. He received his medical degree in 1997 from Humboldt University Berlin and his Board Certification in Neurology in 2005 after completing his residency at the Charité University Hospital in Berlin and the University Hospital Bordeaux. In 2005, he was awarded a PhD in Neuroscience at the University Bordeaux. He was appointed Professor of Neurology at the University Bordeaux in 2012. Prof. Meissner has served on several MDS Committees since 2013, including a leadership role as Chair of the International Education Committee between 2017-2019. He has authored more than 165 peer-reviewed publications in the field of movement disorders. His research interests focus on biological and clinical markers of disease progression in PD and MSA, and treatment development for these disorders in a translational approach. Within his research activities, Prof. Meissner co-chairs the MDS-sponsored MSA Study Group and has coordinated the ARTEMIS consortium between 2014-2019. 

Vision Statement

My vision for MDS is being the uncontested leader in the field of Parkinson’s disease and movement disorders, from a scientific and cultural perspective by bringing together clinicians, scientists and other health professionals from all continents. My contributions to various MDS initiatives have enabled me to significantly grow both professionally and personally while gaining invaluable leadership experiences and insights into the Society. Building on these, I would like to help shaping the Society’s future. In particular, given my expertise and based on my previous experience as Chair of the International Education Committee, I would like to stimulate the development of activities related to education and rare disorders in the field of movement disorders. As a clinical movement disorders specialist and basic science researcher, I would also like to develop initiatives to attract the next generation of basic scientists to the field of movement disorders. Finally, my profound knowledge of European and North American cultures, as well as the experience in line with my recent sabbatical in New Zealand, will facilitate the interaction between different communities. 

  Roongroj Bhidayasiri – IEC Member 2021-2025

Personal Bio

Prof. Bhidayasiri graduated in Medicine from Chulalongkorn University, Thailand, 1993 and trained in neurology and movement disorders in Oxford, London, and UCLA. Prof. Bhidayasiri finally returned to Thailand to establish the first Parkinson's center and movement disorder fellowship in the country. Prof. Bhidayasiri is grateful to AOS colleagues for their support of the 4th AOPMC in Thailand during the heavy political demonstration, and the opportunities to serve in several AOS committees. Prof. Bhidayasiri received the Presidential Service Award from Matt Stern along with Louis Tan for service to the society in 2015. He currently serves as AOS chair, and the COVID pandemic made Prof. Bhidayasiri realize even more the importance of unity, working as a team to increase engagement and lessen disparity within the section. Younger generations are promoted to serve in the Movement Disorders in Asia task force within the AOS. Prof. Bhidayasiri is grateful for the support from AOS peers, MDS friends and Officers, and, importantly, the MDS secretariat. 

Vision Statement

Coming from developing country (Thailand) but trained in developed countries (UK and USA) put me in the position to understand the gaps of knowledge, care, and opportunities, which are not limited to the AOS. Experiences of serving in the AOS during two challenging periods (political demonstration in Thailand in 2014 and COVID-19 pandemic) enable me to understand the act of priorities and be responsive to change, which I hope to benefit MDS to maintain the dominance and continue to grow at the global level. While we continue to enrich the science at a deep level, we should also be inclusive of those who are lack of resources and opportunities. This applies the same for younger generations within our society. I am hoping to represent AOS for active engagement by promoting more AOS contribution at the global level and increasing opportunities to outreach regions from lessons learned from Indochina and Central Asia. At the same time, AOS members are part of the whole MDS community and I hope to increase participation, interactions and networking across sections that we continue to learn and adapt in the virtual world. In the era of technology that is also of my research interest, I will support the implementation of new measures by networking AOS to the rest of the world. 

  Nobutaka Hattori - IEC Member 2021-2025

Personal Bio

PProf. Hattori graduated from Juntendo University School of Medicine in 1985. He received his certification in Neurology from the Japanese Board of Neurology in 1989, and earned his PhD from Juntendo University Graduate School in 1994. From 1995-1998 Prof. Hattori was an Assistant Professor in the Department of Neurology at Juntendo University. He became a lecturer at from 1999-2003, and an Associate Professor from 2003-2006. Since 2006, Prof. Hattori has been Professor and Chairman in the Department of Neurology at Juntendo University, and in 2019 Prof. Hattori became Dean of the Faculty of Medicine at Juntendo University. Prof. Hattori had also served as Chair of the MDS-AOS. 

Vision Statement

I anticipate an increasing number of neurodegenerative diseases as we enter the super-aging society. I would like to improve the educational system for developing intractable neurological diseases, improving diagnostic accuracy, and improving the quality of treatment. In addition, I aim to enhance cultural exchanges among the younger generations and promote cultural exchanges that will bring the world together. In addition, aiming at the post of new corona infectious disease, I aim to develop a medical and therapeutic system in the new normal era. 

  Hyder Jinnah - IEC Member 2021-2025

Personal Bio

Prof. Jinnah received his MD and PhD degrees from the University of California in San Diego in 1993, completed his Neurology Residency at Johns Hopkins Hospital in 1997, and became Professor of Neurology and Human Genetics at Emory in 2008. The vast majority of Prof. Jinnah’s clinical work and research has focused on Movement Disorders, particularly the Dystonias. Prof. Jinnah’s work has included both basic science research and clinical-translational research addressing rare inherited dystonias such as Lesch-Nyhan disease, as well as more common idiopathic adult-onset focal dystonias. Prof. Jinnah has published more than 200 papers, given more than 150 lectures worldwide, and participated in training numerous junior clinicians and investigators at all levels. One major accomplishment was the establishment of the Dystonia Coalition in 2009, a multi-center collaborative research network that now spans more than 40 centers worldwide. This program continues to be a major driving force in collaborative research across many types of dystonia. 

Vision Statement

The MDS is one of the best run professional societies, and I have been honored to be a part of it. During my term as Chair of the CSPC, we made numerous changes to improve the overall efficiency of operations, improve the integration of scientific topics and the quality of presentations for the best congresses possible, and improve transparency and fairness of our processes to promote engagement of all types of members. I envision a similar approach to many things that MDS does now, and may need to do in the future, while maintaining a clear focus on clinical care and education that improves the lives of the patients we serve. 

  Regina Katzenschlager - IEC Member 2021-2025

Personal Bio

Dr. Katzenschlager trained in neurology and psychiatry in Vienna, Austria, and did a 3-year movement disorders fellowship at University College London, UK. She is now Head of the Department of Neurology and Geriatrics at Klinik Donaustadt and of Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders in Vienna, Austria. She is a Guest Professor at Vienna Medical University. She has served as the President of the Austrian Neurological Society (2012- 2014) and is a Board member of the Austrian PD Society. Her research interests are focused on motor and non-motor problems in Parkinson´s disease and their treatment including clinical trials and evidence based medicine. She has served in several roles for the International Parkinson and Movement Disorder Society, including as faculty and course director, and as a Member of the Editorial Board of Movement Disorders, the Executive Committee of the European Section, and as Chair of the Liaison Committee. She has been involved in evidence based medicine related work for many years and currently chairs the MDS Evidence Based Medicine Committee. 

Vision Statement

I have been involved in the activities of the International Parkinson and Movement Disorder Society (MDS) for years and have enjoyed witnessing its growth and its development into the leading global scientific organization in the field. Having served the Society on several committees, including the Executive Committee of the European Section, and in my current role as chair of the Evidence Based Medicine Committee, I would be honored and delighted to continue to actively support the Society´s mission of enhancing awareness, providing education and supporting research. Among other aspects, I would like to see the Society continue its efforts to reach out to a younger generation and to as many underserved parts of the world as feasible, and I would support its on-going strategy of making the geographical and gender distribution of its membership visible in active and leadership roles. 

  Tanya Simuni - IEC Member 2021-2025

Personal Bio

Dr. Tanya Simuni (USA) is Arthur Nielsen Professor of Neurology at Northwestern University, Chicago. She has founded and built the Northwestern movement disorders center that is recognized by the Parkinson Foundation, HDSA, Wilson’s Society and Cure PSP as a Center of Excellence. She is the world recognized expert in Parkinson’s disease specifically disease modification studies. She was the principal investigator on an NIH funded multicenter phase 3 STEADY-PD study. She serves on a number of Steering Committees for PD national and international clinical trials, several committees of the MDS, Parkinson Study Group and the Parkinson Foundation. She serves on the Steering Committee for the 

MJFF PPMI study and served a term on the MJFF Executive Scientific Advisory Board. She has more than hundred publications in peer-reviewed scientific journals and book chapters and has lectured nationally and internationally on PD and other movement disorders. She is highly committed to the education and has served as the residency program director for 13 years, fellowship director and is actively involved in MDS mentorship initiatives as a LEAP Mentor. 

Vision Statement

I will be honored to serve in the leadership role for the Society. If elected into the MDS leadership role, I will bring my expertise and enthusiasm specifically in two areas of my expertise: clinical trials and education. In the domain of clinical trials I will work on expansion of the international collaborations in design and execution of the clinical trials and education. In the domain of clinical research, I will develop educational modules on trials design and execution. I will use my established collaborations with the MJFF to build international platforms for recruitment using novel strategies of multimedia and wide based web access. I also will commit my effort and expertise to further advancing professional and community education on the role of genetic testing in PD research and clinical care. Lastly, I have been involved in a number of initiatives on advancing knowledge and implementation of digital technology in movement disorders research and clinical care. In the domain of education, I have passion and experience in education of the young generation of clinicians and clinical scientists. I would like to expand the existing MDS visiting professorships and school for young neurologists initiatives to allow a broader network of educational opportunities specifically in the countries with unmet needs. 

  Eng-King Tan - IEC Member 2021-2025

Personal Bio

Dr. EK Tan is the Deputy Medical director and Research director at the National Neuroscience Institute, a Professor at Duke-NUS medical school and Lee Kong Chian school of medicine. Dr. Tan has about 500 publications and has served as an editor for several journals including European Journal of Neurology, Journal of Parkinson’s disease, Parkinsonism Related Disorders, Parkinson’s disease, Basal Ganglia. In MDS, he is a founding member of the MDS Asian Oceanic Section, having served two terms including the post of treasurer. He has also been a member of several MDS committees and taskforces including Scientific Issue committee, Congress Scientific Programme committee, CME committee, Dystonia Taskforce, Tremor Study Group. He has lectured at several MDS congresses and received the MDS David Marsden Lectureship award in 2018 and the Yoshi Mizuno Lectureship award in 2016. Dr. Tan has promoted educational activities in MDS including serving in MDS ambassador program and MDS LEAPs program. Dr. Tan’s research interests include clinical and neuroimaging studies, functional genomics and experimental therapeutics in Movement Disorders. 

Vision Statement

I aim to promote movement disorders as a specialty so as to improve the quality of care through better diagnosis and treatment of patients. I aim to also promote and facilitate scientific and educational activities in MDS among physicians, neuroscientists and allied healthcare workers. 

Proxy voting is now open for the 2021-2023 elections for MDS Leadership positions.

Please visit this page to submit your proxy ballot by September 10. In order to vote in the election, members must submit a proxy ballot. The ballots will be tallied at the MDS Business Meeting and Regional Assemblies. 

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice